• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冷冻疗法预防紫杉醇引起的神经病变的安全性和有效性:一项系统评价

The Safety and Efficacy of Cryotherapy in the Prevention of Paclitaxel-Induced Neuropathy: A Systematic Review.

作者信息

Hossain Md Fahad, Kharel Manish, Rajib Mostafa Hasan, Khan Mahfuza A, Anwar Md Yasin, Lamsal Yogesh, Aziz Syed Nurul

机构信息

Hospital Medicine, Ministry of Health, Upazila Health Complex, Kishoreganj, BGD.

Medicine and Surgery, Jahurul Islam Medical College, Bhagalpur, BGD.

出版信息

Cureus. 2023 Aug 24;15(8):e44026. doi: 10.7759/cureus.44026. eCollection 2023 Aug.

DOI:10.7759/cureus.44026
PMID:37664355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10473832/
Abstract

The chemotherapeutic agent paclitaxel has significantly enhanced the treatment of various types of cancer. However, the quality of life of cancer patients is often impacted by the painful and dose-restrictive paclitaxel side effect known as paclitaxel-induced peripheral neuropathy (PIPN). A non-pharmacological method called cryotherapy has shown promise in alleviating PIPN-related symptoms. In this systematic review, we aimed to evaluate the safety and effectiveness of cryotherapy in preventing PIPN. The review analyzed four randomized controlled trials (RCTs) involving individuals treated with paclitaxel for breast and gynecological cancer. Cryotherapy showed success in lowering PIPN symptoms in several studies, as judged by various outcome measures, although the findings varied. The safety profile of cryotherapy was typically good, with minimal side effects. However, methodological variations and small sample sizes in the studies analyzed limit drawing definitive conclusions from them. To obtain conclusive evidence, studies with standardized techniques and larger sample sizes are required. Further research is necessary to understand cryotherapy's potential mechanisms and long-term effects. This review highlights the potential of cryotherapy in the management of PIPN, explains how it works, and suggests future research topics to improve its application.

摘要

化疗药物紫杉醇显著改善了各类癌症的治疗效果。然而,癌症患者的生活质量常常受到紫杉醇引起的外周神经病变(PIPN)这种疼痛且限制剂量的副作用的影响。一种名为冷冻疗法的非药物方法在缓解与PIPN相关的症状方面显示出了前景。在这项系统评价中,我们旨在评估冷冻疗法预防PIPN的安全性和有效性。该评价分析了四项随机对照试验(RCT),这些试验涉及接受紫杉醇治疗的乳腺癌和妇科癌症患者。尽管研究结果各不相同,但根据各种结局指标判断,冷冻疗法在多项研究中成功减轻了PIPN症状。冷冻疗法的安全性通常良好,副作用极小。然而,所分析研究中的方法差异和样本量较小限制了从中得出明确结论。为了获得确凿证据,需要采用标准化技术且样本量更大的研究。有必要进行进一步研究以了解冷冻疗法的潜在机制和长期效果。本评价突出了冷冻疗法在管理PIPN方面的潜力,解释了其作用方式,并提出了未来改善其应用的研究课题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2943/10473832/856071a7bc69/cureus-0015-00000044026-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2943/10473832/ffdeb7360379/cureus-0015-00000044026-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2943/10473832/856071a7bc69/cureus-0015-00000044026-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2943/10473832/ffdeb7360379/cureus-0015-00000044026-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2943/10473832/856071a7bc69/cureus-0015-00000044026-i02.jpg

相似文献

1
The Safety and Efficacy of Cryotherapy in the Prevention of Paclitaxel-Induced Neuropathy: A Systematic Review.冷冻疗法预防紫杉醇引起的神经病变的安全性和有效性:一项系统评价
Cureus. 2023 Aug 24;15(8):e44026. doi: 10.7759/cureus.44026. eCollection 2023 Aug.
2
Preventive effects of self-administered cryotherapy on paclitaxel-induced peripheral neuropathy in patients with early-stage breast cancer: a propensity score analysis.自我实施冷冻疗法对早期乳腺癌患者紫杉醇诱导的周围神经病变的预防作用:倾向评分分析。
Pharmazie. 2021 Jun 1;76(6):261-265. doi: 10.1691/ph.2021.1398.
3
A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral Neuropathy.神经保护剂治疗紫杉醇所致周围神经病变有效性的系统评价与荟萃分析
Front Oncol. 2022 Jan 5;11:763229. doi: 10.3389/fonc.2021.763229. eCollection 2021.
4
Differential methylation and expression of genes in the hypoxia-inducible factor 1 signaling pathway are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors and with preclinical models of chemotherapy-induced neuropathic pain.缺氧诱导因子 1 信号通路中基因的甲基化和表达差异与乳腺癌幸存者紫杉醇诱导的周围神经病变以及化疗诱导的神经病理性疼痛的临床前模型有关。
Mol Pain. 2020 Jan-Dec;16:1744806920936502. doi: 10.1177/1744806920936502.
5
Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors.乳腺癌幸存者紫杉醇诱导周围神经病变中线粒体功能障碍相关基因和途径的表达。
Mol Pain. 2018 Jan-Dec;14:1744806918816462. doi: 10.1177/1744806918816462. Epub 2018 Nov 14.
6
Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer.乳腺癌患者紫杉醇诱导的周围神经病的风险因素。
BMC Cancer. 2018 Oct 5;18(1):958. doi: 10.1186/s12885-018-4869-5.
7
Acupuncture for Paclitaxel-Induced Peripheral Neuropathy: A Review of Clinical and Basic Studies.针刺治疗紫杉醇引起的周围神经病变:临床与基础研究综述
J Pain Res. 2021 Apr 15;14:993-1005. doi: 10.2147/JPR.S296150. eCollection 2021.
8
Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers.血液神经丝轻链作为监测和预测妇科癌症患者紫杉醇诱导的周围神经病变的生物标志物。
Front Oncol. 2022 Aug 17;12:942960. doi: 10.3389/fonc.2022.942960. eCollection 2022.
9
Estrogen decline is a risk factor for paclitaxel-induced peripheral neuropathy: Clinical evidence supported by a preclinical study.雌激素下降是紫杉醇诱导的周围神经病变的一个危险因素:一项临床前研究支持的临床证据。
J Pharmacol Sci. 2021 May;146(1):49-57. doi: 10.1016/j.jphs.2021.03.001. Epub 2021 Mar 10.
10
An up-to-date view of paclitaxel-induced peripheral neuropathy.紫杉醇诱导的周围神经病的最新观点。
J Cancer Res Ther. 2023 Dec 1;19(6):1501-1508. doi: 10.4103/jcrt.jcrt_1982_22. Epub 2023 Dec 28.

本文引用的文献

1
Efficacy of cryotherapy on chemotherapy-induced peripheral neuropathy in patients with breast cancer: a propensity score-matched study.冷冻疗法对乳腺癌患者化疗引起的周围神经病变的疗效:一项倾向评分匹配研究。
Ann Med Surg (Lond). 2023 May 23;85(6):2695-2703. doi: 10.1097/MS9.0000000000000906. eCollection 2023 Jun.
2
Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling.提高化疗期间的生活质量:大麻素、冷冻疗法和头皮冷却。
Am Soc Clin Oncol Educ Book. 2023 Jun;43:e390428. doi: 10.1200/EDBK_390428.
3
Prioritization and sequential exclusion of articles in systematic reviews.
系统评价中文章的优先级确定与顺序排除
Campbell Syst Rev. 2022 Mar 27;18(2):e1229. doi: 10.1002/cl2.1229. eCollection 2022 Jun.
4
Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy (CIPN) with Non-Pharmacological Interventions: Clinical Recommendations from a Systematic Scoping Review and an Expert Consensus Process.非药物干预防治化疗所致周围神经病(CIPN):系统评价和专家共识过程的临床建议。
Med Sci (Basel). 2023 Jan 30;11(1):15. doi: 10.3390/medsci11010015.
5
A global survey on the utilization of cryotherapy and compression therapy for the prevention of chemotherapy-induced peripheral neuropathy.一项关于冷冻疗法和压迫疗法在预防化疗引起的周围神经病中的应用的全球调查。
Support Care Cancer. 2022 Dec;30(12):10001-10007. doi: 10.1007/s00520-022-07383-x. Epub 2022 Oct 10.
6
Effect of cryotherapy on paclitaxel-induced peripheral neuropathy of the hand in female breast cancer patients: A prospective self-controlled study.冷冻疗法对女性乳腺癌患者紫杉醇诱导的手部周围神经病变的影响:一项前瞻性自身对照研究。
Int J Nurs Pract. 2023 Aug;29(4):e13094. doi: 10.1111/ijn.13094. Epub 2022 Aug 15.
7
Efficacy of Siriraj, in-house-developed, frozen gloves for cold therapy reduction of chemotherapy-induced peripheral neuropathy in gynecological cancer patients: randomized controlled trial.Siriraj 医院内部研制的冷冻手套用于减轻妇科癌症患者化疗引起的周围神经病变的疗效:随机对照试验。
Support Care Cancer. 2022 Jun;30(6):4835-4843. doi: 10.1007/s00520-022-06890-1. Epub 2022 Feb 11.
8
Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis.冷冻疗法预防紫杉烷类药物所致周围神经病变的Meta分析
Front Oncol. 2021 Nov 29;11:781812. doi: 10.3389/fonc.2021.781812. eCollection 2021.
9
Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy.紫杉醇诱导的周围神经病变的发病机制
Toxics. 2021 Sep 22;9(10):229. doi: 10.3390/toxics9100229.
10
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.《PRISMA 2020声明:报告系统评价的更新指南》
Syst Rev. 2021 Mar 29;10(1):89. doi: 10.1186/s13643-021-01626-4.